1. Home
  2. BLMN vs OCUL Comparison

BLMN vs OCUL Comparison

Compare BLMN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$5.68

Market Cap

460.3M

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.34

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
OCUL
Founded
1988
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
460.3M
1.9B
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
BLMN
OCUL
Price
$5.68
$8.34
Analyst Decision
Hold
Strong Buy
Analyst Count
9
10
Target Price
$8.33
$23.56
AVG Volume (30 Days)
2.5M
3.5M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
5.22%
N/A
EPS Growth
106.71
N/A
EPS
0.10
N/A
Revenue
$4,213,346,000.00
$1,990,000.00
Revenue This Year
$2.07
$7.93
Revenue Next Year
$1.83
$94.00
P/E Ratio
$57.50
N/A
Revenue Growth
N/A
3.48
52 Week Low
$5.19
$6.23
52 Week High
$10.70
$16.44

Technical Indicators

Market Signals
Indicator
BLMN
OCUL
Relative Strength Index (RSI) 47.74 47.20
Support Level $5.40 $8.36
Resistance Level $7.42 $12.38
Average True Range (ATR) 0.32 0.46
MACD 0.04 0.05
Stochastic Oscillator 52.69 72.63

Price Performance

Historical Comparison
BLMN
OCUL

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: